RIZZI LAURA

Role
Assistant Professor  
Academic disciplines
Pharmacology (BIOS-11/A)
Scientific-Disciplinary Group:
PHARMACOLOGY (05/BIOS-11)
Office phone
Room:
  • U08, Floor: 2, Room: 2021

Publications

  • Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186 [10.1016/j.biopha.2025.118044]. Detail

  • Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Detail

  • Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells. Intervento presentato a: Innovazione e malattie rare: dalla ricerca preclinica al paziente, Bari, Italia. Detail

  • Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Sartori, E., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 42° Congresso Nazionale SIF. Science today for a better medicine tomorrow, Sorrento, Italia. Detail

  • Bianchi, V., Rizzi, L., Somaa, F. (2023). The role of nutrition on Parkinson’s disease: a systematic review. NUTRITIONAL NEUROSCIENCE, 26(7), 605-628 [10.1080/1028415X.2022.2073107]. Detail

Research projects

Disease-modifying effects of hexarelin and JMV2894 in experimental models of multiple sclerosis
Year: 2023
Call: FAQC 2023 - prima finestra
Grantors: Università degli Studi di MILANO-BICOCCA
PNRR per la Missione 4, componente 2 Investimento 1.1- Avviso 104/2022 | Development of Growth Hormone Secretagogues as novel therapeutical tools for the treatment of multiple sclerosis
Year: 2022
Call: Bando PRIN 2022
Grantors: MINISTERO DELL'UNIVERSITA' E DELLA RICERCA (MUR)

Awards

Awards

  • Best poster communication award, Società Italiana di Farmacologia -SIF, 2019

Research and teaching assignments

  • Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2024
  • Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2019 - 2024